Evidence map›Paper›PMID 38233908›Full record

ArticleBMC public health2024

A randomized controlled trial of the dissemination of an mHealth intervention for improving health outcomes: the WiseApp for Spanish-speakers living with HIV study protocol.

Felix Olaya, Maeve Brin, Pamela Baez Caraballo, Mina Halpern, Haomiao Jia, Sergio Ozoria Ramírez, Janeth Juarez Padilla, Samantha Stonbraker, Rebecca Schnall

Registry-linked trialOpen access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in BMC public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05398185 (WiseApp for Spanish-Speaking Latino Persons Living With HIV), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05398185 naactive not recruitingnot on this map

WiseApp for Spanish-Speaking Latino Persons Living With HIV (PLWH) in the United States (US) and the Dominican Republic (DR)

TypeinterventionalSponsorColumbia UniversityRan2023 to 2027Enrolled241ConditionsHIV Infections, Acquired Immune Deficiency Syndrome, Sexually Transmitted Diseases, ViralArmsCleverCap
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 3 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Felix OlayaSchool of Nursing, Columbia University, 560 W 168th St, New York, NY, 10032, USA.
Maeve BrinSchool of Nursing, Columbia University, 560 W 168th St, New York, NY, 10032, USA.
Pamela Baez CaraballoClínica de Familia La Romana, La Romana, Dominican Republic.
Mina HalpernClínica de Familia La Romana, La Romana, Dominican Republic.
Haomiao JiaSchool of Nursing, Columbia University, 560 W 168th St, New York, NY, 10032, USA.
Sergio Ozoria RamírezNYU Steinhardt School of Culture, Education, and Human Development, New York, NY, 10003, USA.
Janeth Juarez PadillaNYU School of Medicine, New York, NY, 10016, USA.
Samantha StonbrakerUniversity of Colorado College of Nursing, Anschutz Medical Campus, Aurora, CO, 80045, USA.
Rebecca SchnallSchool of Nursing, Columbia University, 560 W 168th St, New York, NY, 10032, USA. rb897@cumc.columbia.edu.
Columbia University · USNew York University · USUniversity of Colorado Anschutz Medical Campus · US

Funding

Dissemination of the WiseApp for Improving Health Outcomes Across SettingsR18HS028523 · AHRQ · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SCHNALL, REBECCA · 2021 to 2024
$1.6M
AHRQ HHS R18 HS028523
6 · The paper itself

Abstract

backgroundWhile there is no cure for HIV, adherence to antiretroviral therapy can extend the lifespan and improve the quality of life of people with HIV. Despite the global reduction of HIV infection rates in recent years, New York City and La Romana, Dominican Republic, continue to report high infection rates among Latino populations. Many people with HIV remain virally unsuppressed in these geographic hotspots, suggesting a need for additional interventions to overcome medication adherence barriers. Tailored and culturally appropriate mobile health (mHealth) technology can be an engaging way to improve adherence. The primary objective of this trial is to test the effectiveness of an mHealth tool to improve HIV medication adherence among Spanish-speaking people living in New York City and the Dominican Republic.

methodsThe WiseApp study is a two-arm randomized controlled trial among 248 people with HIV across the New York and Dominican Republic sites over the course of 12 months. Participants are randomly assigned to either receive a CleverCap pill bottle that is linked to the WiseApp (intervention) or standard of care (control). All participants complete surveys at baseline, 3-month, 6-month, and 12-month follow-up visits and the study team obtains HIV-1 viral load and CD4 count results through blood draw at each study timepoint. DISCUSSION: The use of mHealth technologies to improve medication adherence among people with HIV has been implemented in recent years. Although some studies have found improvement in adherence to antiretroviral therapy in the short term, there is limited information about how these interventions improve adherence among Spanish-speaking populations. Disproportionate rates of HIV infection among Latinos in New York City suggest an existing inequitable approach in reaching and treating this population. Due to a lack of mHealth studies with Latino populations, and apps tailored to Spanish-speakers, the WiseApp study will not only demonstrate the effectiveness of this particular mHealth app but will also contribute to the mHealth research community as a whole.

trial registrationThis trial was registered with Clinicaltrials.gov (NCT05398185) on 5/31/2022.

Indexed as

HIV InfectionsMobile ApplicationsTelemedicineHumansNew York CityQuality of LifeRandomized Controlled Trials as TopicAntiretroviral therapy (ART)LatinosMedication adherenceMobile Health (mHealth)People with HIV (PWH)Spanish speakers

Identifiers

PMID38233908
PMCPMC10792787
OpenAlexW4390951271

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.